98 related articles for article (PubMed ID: 26338349)
1. Mechanism-based inactivation of cytochrome P450 2B6 by isopsoralen.
Lu D; Ji L; Zheng L; Cao J; Peng Y; Zheng J
Xenobiotica; 2016; 46(4):335-41. PubMed ID: 26338349
[TBL] [Abstract][Full Text] [Related]
2. Mechanism-based inactivation of cytochrome P450 2B6 by isoimperatorin.
Cao J; Zheng L; Ji L; Lu D; Peng Y; Zheng J
Chem Biol Interact; 2015 Jan; 226():23-9. PubMed ID: 25500267
[TBL] [Abstract][Full Text] [Related]
3. Imperatorin is a mechanism-based inactivator of CYP2B6.
Zheng L; Cao J; Lu D; Ji L; Peng Y; Zheng J
Drug Metab Dispos; 2015 Jan; 43(1):82-8. PubMed ID: 25378064
[TBL] [Abstract][Full Text] [Related]
4. Psoralen, a mechanism-based inactivator of CYP2B6.
Ji L; Lu D; Cao J; Zheng L; Peng Y; Zheng J
Chem Biol Interact; 2015 Oct; 240():346-52. PubMed ID: 26335194
[TBL] [Abstract][Full Text] [Related]
5. Oxypeucedanin is a Mechanism-based Inactivator of CYP2B6 and CYP2D6.
Zhang K; Li Y; Fu Y; Cui T; Wang Q; Mao X; Peng Y; Zheng J
Curr Drug Metab; 2021; 22(11):882-892. PubMed ID: 34191696
[TBL] [Abstract][Full Text] [Related]
6. Mechanism-based inactivation of CYP2C9 by linderane.
Wang H; Wang K; Mao X; Zhang Q; Yao T; Peng Y; Zheng J
Xenobiotica; 2015; 45(12):1037-46. PubMed ID: 26068520
[TBL] [Abstract][Full Text] [Related]
7. Identification of 17-alpha-ethynylestradiol-modified active site peptides and glutathione conjugates formed during metabolism and inactivation of P450s 2B1 and 2B6.
Kent UM; Lin HL; Mills DE; Regal KA; Hollenberg PF
Chem Res Toxicol; 2006 Feb; 19(2):279-87. PubMed ID: 16485904
[TBL] [Abstract][Full Text] [Related]
8. Mechanism-based inactivation of cytochrome P450 2B6 by a novel terminal acetylene inhibitor.
Fan PW; Gu C; Marsh SA; Stevens JC
Drug Metab Dispos; 2003 Jan; 31(1):28-36. PubMed ID: 12485950
[TBL] [Abstract][Full Text] [Related]
9. Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by 2-phenyl-2-(1-piperidinyl)propane.
Chun J; Kent UM; Moss RM; Sayre LM; Hollenberg PF
Drug Metab Dispos; 2000 Aug; 28(8):905-11. PubMed ID: 10901699
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of inactivation of human cytochrome P450 2B6 by phencyclidine.
Jushchyshyn MI; Wahlstrom JL; Hollenberg PF; Wienkers LC
Drug Metab Dispos; 2006 Sep; 34(9):1523-9. PubMed ID: 16782764
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of bupropion metabolism by selegiline: mechanism-based inactivation of human CYP2B6 and characterization of glutathione and peptide adducts.
Sridar C; Kenaan C; Hollenberg PF
Drug Metab Dispos; 2012 Dec; 40(12):2256-66. PubMed ID: 22936314
[TBL] [Abstract][Full Text] [Related]
12. Nitidine Chloride Is a Mechanism-Based Inactivator of CYP2D6.
Mao X; Hu Z; Wang Q; Zhang N; Zhou S; Peng Y; Zheng J
Drug Metab Dispos; 2018 Aug; 46(8):1137-1145. PubMed ID: 29773554
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic study of bergamottin-induced inactivation of CYP2C9.
Liu Y; Zhang S; Jiang T; Tan R; Fu Y; Yang X; Gong B; Zou Y; Li W; Zheng J
Food Chem Toxicol; 2021 Jul; 153():112278. PubMed ID: 34019943
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of psoralen and isopsoralen as potent CYP1A2 reversible and time-dependent inhibitors in human and rat preclinical studies.
Zhuang XM; Zhong YH; Xiao WB; Li H; Lu C
Drug Metab Dispos; 2013 Nov; 41(11):1914-22. PubMed ID: 23975028
[TBL] [Abstract][Full Text] [Related]
15. The mechanism-based inactivation of human cytochrome P450 2B6 by phencyclidine.
Jushchyshyn MI; Kent UM; Hollenberg PF
Drug Metab Dispos; 2003 Jan; 31(1):46-52. PubMed ID: 12485952
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship and elucidation of the determinant factor(s) responsible for the mechanism-based inactivation of cytochrome P450 2B6 by substituted phenyl diaziridines.
Kobayashi Y; Sridar C; Kent UM; Puppali SG; Rimoldi JM; Zhang H; Waskell L; Hollenberg PF
Drug Metab Dispos; 2006 Dec; 34(12):2102-10. PubMed ID: 16997911
[TBL] [Abstract][Full Text] [Related]
17. Mechanism-based inactivation of cytochrome P450 2B6 by methadone through destruction of prosthetic heme.
Amunugama HT; Zhang H; Hollenberg PF
Drug Metab Dispos; 2012 Sep; 40(9):1765-70. PubMed ID: 22685215
[TBL] [Abstract][Full Text] [Related]
18. The grapefruit juice effect is not limited to cytochrome P450 (P450) 3A4: evidence for bergamottin-dependent inactivation, heme destruction, and covalent binding to protein in P450s 2B6 and 3A5.
Lin HL; Kent UM; Hollenberg PF
J Pharmacol Exp Ther; 2005 Apr; 313(1):154-64. PubMed ID: 15608076
[TBL] [Abstract][Full Text] [Related]
19. Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen.
Koenigs LL; Peter RM; Thompson SJ; Rettie AE; Trager WF
Drug Metab Dispos; 1997 Dec; 25(12):1407-15. PubMed ID: 9394031
[TBL] [Abstract][Full Text] [Related]
20. Mutation of a single residue (K262R) in P450 2B6 leads to loss of mechanism-based inactivation by phencyclidine.
Shebley M; Hollenberg PF
Drug Metab Dispos; 2007 Aug; 35(8):1365-71. PubMed ID: 17460030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
